title: Upper renal tract deterioration after cyclophosphamide-induced cystitis: the case for monitoring after cyclophosphamide therapy.
authors.affiliation: Department of Urology, Meath Hospital, Dublin, Ireland.
authors.forename: J P
authors.initials: JP
authors.lastname: Sweeney
authors.forename: C W
authors.initials: CW
authors.lastname: Fan
authors.forename: J A
authors.initials: JA
authors.lastname: Keogh
authors.forename: J A
authors.initials: JA
authors.lastname: Thornhill
mesh_terms: D000328:Adult; D003520:Cyclophosphamide / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced*; D005260:Female; D005355:Fibrosis / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D014515:Ureteral Diseases / Q000139:chemically induced*; D014718:Vesico-Ureteral Reflux / Q000209:etiology
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide